OPKO Health, Inc. Finance Lease, Liability
OPKO Health, Inc. (OPK) had Finance Lease, Liability of $4.04 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:FinanceLeaseLiability · last filed 2026-08-28
- 2026-06-30: Finance Lease, Liability $4.04M.
- 2026-03-31: Finance Lease, Liability $4.53M.
- 2025-12-31: Finance Lease, Liability $5.08M.
- 2025-09-30: Finance Lease, Liability $4.82M.
| Period end | Finance Lease, Liability |
|---|---|
| 2026-06-30 | $4.04M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $4.53M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $5.08M 10-K · filed 2026-02-26 |
| 2025-09-30 | $4.82M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $5.25M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $5.42M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $5.74M 10-K · filed 2025-03-03 |
| 2024-09-30 | $6.54M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $6.28M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $6.77M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $10.10M 10-K · filed 2024-03-01 |
| 2023-09-30 | $10.61M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $10.08M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $10.86M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $9.90M 10-K · filed 2023-02-27 |
| 2022-09-30 | $6.93M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.21M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.32M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $5.18M 10-K · filed 2022-03-01 |
| 2021-09-30 | $4.11M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $4.64M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $4.79M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $5.26M 10-K · filed 2021-02-18 |
| 2020-09-30 | $4.88M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $5.39M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $6.09M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $6.79M 10-K · filed 2020-03-02 |
| 2019-09-30 | $7.31M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $7.68M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $8.06M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |